YS

Yashica Singh

Active Director Director DIN 09865794
DIN 09865794 First appointment Jan 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Yashica Singh

Data last updated:

Yashica Singh is a Director at Yashica Meditech Limited (since 2023). The company operates in Healthcare. Yashica Meditech Limited reported revenue of ₹55.8 Lakh (FY 2025).

DIN 09865794
Primary Designation Director
Industry Healthcare
First Appointment 20 Jan 2023
Oldest Company Age 3 yrs
Largest company Yashica Meditech Limited · ₹55.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yashica Meditech Limited U72900UP2023PLC177447
Director20 Jan 20232023₹55.8 Lakh (FY 2025)Active

Board colleagues of Yashica Singh

Directorship timeline

Open interactive timeline →
Yashica Meditech Limited
Premium access

Shareholding and investment profile for Yashica Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yashica Singh

Yashica Singh currently holds 1 directorship: Yashica Meditech Limited (Director, since 20 Jan 2023, revenue ₹55.8 Lakh (FY 2025)).

Yashica Singh was first appointed on 20 Jan 2023 as Director at Yashica Meditech Limited.

The current boards of Yashica Singh's companies include Ramesh Pratap Singh (Yashica Meditech Limited), Shiv Shanker Singh (Yashica Meditech Limited), Surya Pratap Singh (Yashica Meditech Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available